latest news on tirzepatide FDA says the weight-loss drug shortage is over Peptide of the Week: Tirzepatide,

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)

Not because you are forcing yourself to eat less, but because fullness arrives sooner and lasts longer

For participants taking 10 mg of tirzepatide, there was an average reduction in systolic blood pressure of 10.6 mmHg

Cholesterol, glucose and insulin levels, liver fat, and blood pressure all appear to improve with these medications

Enhanced Muscle Recovery: Supports the body's natural recovery processes, beneficial for both athletes and those engaged in regular physical activity

Prior to this approval, the standard ceiling was 2.4 mg per week